Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WikiLeaks Releases Draft Patent Chapter Of Trans-Pacific Free Trade Pact

This article was originally published in The Gray Sheet

Executive Summary

The draft text highlights some key disagreements on intellectually property law questions between countries negotiating the comprehensive Trans-Pacific Partnership free trade agreement, including those related to method patents.

You may also be interested in...



India-Style Patent Laws Targeted In Trans-Pacific Trade Negotiations

Draft intellectual property chapter of the Trans-Pacific Partnership includes a provision prohibiting signatories from denying patents solely because a product did not show enhanced efficacy over a known product.

Free Trade Talks In Asia And Europe Impeded By Government Shutdown

As the shutdown continues, President Obama’s absence at negotiations on the Trans-Pacific Partnership could delay finalization of the free trade agreement. In addition, talks toward an EU-U.S. trade pact were canceled. Both agreements are expected to address device-specific trade issues.

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel